Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in patients undergoing cemented total knee arthroplasty
NCT05559268Phase 4Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of denosumab in osteoarthritis (OA), sponsored by The Affiliated Hospital of Qingdao University. Status: unknown.
02
Drugs
denosumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05559268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05559268.